NVIDIA and Lilly Announce Co-Innovation AI Lab to Reinvent Drug Discovery in the Age of AI

NVIDIA and Eli Lilly have announced a new AI co-innovation lab focused on applying AI to tackle challenges in the pharmaceutical industry. The lab will bring together Lilly’s expertise in drug discovery with NVIDIA’s leadership in AI and accelerated computing to accelerate medicine development.